Diagnostic Accuracy of Stool Tests for Colorectal Cancer Surveillance in Hodgkin Lymphoma Survivors
Berbel L.M. Ykema(The Netherlands Cancer Institute), Monique E. van Leerdam(Leiden University Medical Center), Cécile P.M. Janus(Erasmus MC Cancer Institute), Lisanne S. Rigter(Dutch Cancer Society), Margriet Lemmens(The Netherlands Cancer Institute), Judith M. Roesink(University Medical Center Utrecht), Wieke H.M. Verbeek(Vrije Universiteit Amsterdam), Leon M.G. Moons(University Medical Center Utrecht), Manon C.W. Spaander(Erasmus University Rotterdam), John Raemaekers(Radboud University Nijmegen), Flora E. van Leeuwen(The Netherlands Cancer Institute), Eefke Petersen(University Medical Center Utrecht), Tanya M. Bisseling(Radboud University Nijmegen), Andrea Gini, Pieternella J. Lugtenburg(Erasmus MC Cancer Institute), Jan Paul de Boer, Iris Lansdorp‐Vogelaar(Erasmus University Rotterdam), Gerrit A. Meijer(The Netherlands Cancer Institute), Beatriz Carvalho(Centro Universitário das Faculdades Metropolitanas Unidas), Richard van der Maazen, Pétur Snæbjörnsson(University of Iceland), Berthe M.P. Aleman(The Netherlands Cancer Institute)
Cited by 6
Related Papers
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
|European Heart Journal|2022|2.7k
AACR Project GENIE: Powering Precision Medicine through an International Consortium
|Cancer Discovery|2017|2k
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study
|The Lancet|2018|1.7k
Genome-wide cell-free DNA fragmentation in patients with cancer
|Nature|2019|1.5k
Direct detection of early-stage cancers using circulating tumor DNA
|Science Translational Medicine|2017|1.1k